Fundamental dimension Equity attribute | DTIPeer $1.73▲+1.47% Cap $60.86MP/E -21.3x QuantScore51/100 | ACDCPeer $4.07▲+5.44% Cap $741.2MP/E -1.7x QuantScore30/100 | AROCLeader $29.12▲+2.57% Cap $5.11BP/E 15.7x QuantScore56/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
16/100 |
25/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 70/100 | 80/100 |
Health Piotroski, Altman Z, leverage & liquidity | 44/100 | 7/100 | 33/100 |
Growth Revenue / earnings growth & margins | 28/100 | 1/100 | 65/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 47/100 | 80/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -21.3x | -1.7x | 15.7x |
Forward P/E (next FY) | 21.1x | -3.1x | 16.9x |
EV / EBITDA (TTM) | 4.8x | 14.6x | 9.3x |
Price / Sales | 0.4x | 0.4x | 3.4x |
Price / Free Cash Flow | -5.9x | -12.2x | 17.5x |
PEG ratio | -1.89 | 0.05 | 0.38 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 4 / 9 | 8 / 9 |
Altman Z-Score | 1.17 (Distress) | 0.13 (Distress) | 1.12 (Distress) |
Total debt / equity | 0.66 | 1.98 | 1.52 |
Quick ratio | 1.5x | 0.6x | 0.9x |
Interest coverage | 1.5x | -1.6x | 2.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.4% | -11.4% | +28.7% |
Net income growth YoY | -224.8% | -71.5% | +87.1% |
Gross margin (TTM) | 68.0% | 4.6% | 58.1% |
Operating margin (FY) | 5.5% | -6.9% | 38.7% |
FCF margin (FY) | -1.2% | 1.0% | 8.0% |
5. Trailing price performancePrice change over period |
1M return | -29.6% | -11.7% | -4.3% |
3M return | -25.3% | -4.5% | -19.4% |
6M return | -48.0% | -44.9% | -22.0% |
Year to date | -29.6% | +4.6% | +11.9% |
1Y return | -26.6% | -5.6% | +13.9% |
3Y return | -55.2% | -54.9% | +127.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $3.43 +99.0% upside | $8.27 +103.1% upside | $21.78 -25.2% premium |
Wall Street consensus target | $2.80 +62.3% · range $2.80–$2.80 | $5.50 +35.1% · range $5.00–$6.00 | $42.17 +44.8% · range $40.00–$46.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 0% Buy67% Hold33% Sell | 83% Buy17% Hold-0% Sell |